Wechsler Scale Intelligence Testing in Males with Dystrophinopathies: A Review and Meta-Analysis
- PMID: 36421868
- PMCID: PMC9688319
- DOI: 10.3390/brainsci12111544
Wechsler Scale Intelligence Testing in Males with Dystrophinopathies: A Review and Meta-Analysis
Abstract
Background: Intelligence scores in males with Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) remain a major issue in clinical practice. We performed a literature review and meta-analysis to further delineate the intellectual functioning of dystrophinopathies.
Method: Published, peer-reviewed articles assessing intelligence, using Wechsler Scales, of males with DMD or BMD were searched from 1960 to 2022. Meta-analysis with random-effects models was conducted, assessing weighted, mean effect sizes of full-scale IQ (FSIQ) scores relative to normative data (Mean = 100, Standard Deviation = 15). Post hoc we analysed differences between performance and verbal intelligence scores.
Results: 43 studies were included, reporting data on 1472 males with dystrophinopathies; with FSIQ scores available for 1234 DMD (k = 32) and 101 BMD (k = 7). DMD males score, on average, one standard deviation below average (FSIQ = 84.76) and significantly lower than BMD (FSIQ = 92.11). Compared to a previous meta-analysis published in 2001, we find, on average, significantly higher FSIQ scores in DMD.
Conclusion: Males with Duchenne have, on average, significantly lower FSIQ scores than BMD males and the general population. Clinicians must consider lower intelligence in dystrophinopathies to ensure good clinical practice.
Keywords: Wechsler Intelligence Scales; dystrophinopathies; meta-analysis.
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Figures
References
-
- Birnkrant D.J., Bushby K., Bann C.M., Apkon S.D., Blackwell A., Colvin M.K., Cripe L., Herron A.R., Kennedy A., Kinnett K., et al. Diagnosis and management of Duchenne muscular dystrophy, part 3: Primary care, emergency management, psychosocial care, and transitions of care across the lifespan. Lancet Neurol. 2018;17:445–455. doi: 10.1016/S1474-4422(18)30026-7. - DOI - PMC - PubMed
-
- Doorenweerd N., Hooijmans M., Schubert S.A., Webb A.G., Straathof C.S., van Zwet E.W., van Buchem M.A., Verschuuren J.J., Hendriksen J.G., Niks E.H., et al. Proton Magnetic Resonance Spectroscopy Indicates Preserved Cerebral Biochemical Composition in Duchenne Muscular Dystrophy Patients. J. Neuromuscul. Dis. 2017;4:53–58. doi: 10.3233/JND-160201. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
